Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway-Reference-Cited by-同舟云学术

Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway

Published:2023-11 Issue: Volume:167 Page:115567
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhu Xu,Huang Nannan,Ji Yao^ORCID,Sheng Xinling,Huo Juanjuan,Zhu Yuan,Huang Menghuan,He Wei,Ma Junting

Funder

National Natural Science Foundation of China

Anhui Medical University

Anhui Provincial Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference58 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Epidemiology of esophageal squamous cell carcinoma;Abnet;Gastroenterology,2018

3. Advances and challenges in the treatment of esophageal cancer;He;Acta Pharm. Sin. B,2021

4. Esophageal cancer;Enzinger;N. Engl. J. Med,2003

5. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron;International Journal of Pharmaceutics;2024-09

2. Exploring the interplay between iron metabolism imbalance and esophageal cancer;Oncologie;2024-07-01

3. Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets;Biomedicine & Pharmacotherapy;2024-06

4. Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches;Drug Design, Development and Therapy;2024-06

5. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway;Experimental Cell Research;2024-05